ESOP Valuation for Unlisted Companies in India — Companies Act, Income Tax, Ind AS 102, and FEMA Compliance

Employee Stock Option Plans carry more regulatory complexity than most founders and CFOs initially expect. A single ESOP grant in an Indian unlisted company simultaneously touches Section 62 of the Companies Act 2013, Section 17(2)(vi) of the Income Tax Act, Rule 3(8) of the Income Tax Rules, Ind AS 102, and FEMA if any non-resident employees are in scope. Mumbai is home to India’s largest concentration of growth-stage companies, pre-IPO entities, and financial services businesses operating ESOP schemes — and the IBBI Registered Valuer’s role sits at the foundation of this entire compliance stack. The grant-date equity valuation report is the document on which every subsequent compliance obligation is calibrated.

Under Section 62(1)(b) of the Companies Act, when shares are issued to employees under an ESOP scheme, the issue price must not be below fair market value as determined by a registered valuer. The IBBI Registered Valuer prepares a per-share FMV report as of the grant date. This is not the same as the investor valuation of the company — investor rounds typically price preferred shares with protective rights that command a premium over common equity. The ESOP valuation must separately assess the common equity value, which for early-stage companies may be thirty to sixty percent below the headline investor valuation depending on the preference stack, liquidation preferences, and anti-dilution protections outstanding.

Why the ESOP Grant-Date Valuation Report Is the Foundation of Your Entire Compliance Stack

The DCF method is the primary approach for unlisted companies with a demonstrable revenue or growth trajectory. The valuer must project free cash flows over a forecast horizon, apply a terminal value, and discount the aggregate at a WACC that reflects the company’s capital structure, sector risk, and stage risk. For pre-revenue companies, the income approach must be cross-checked against a market approach using comparable transaction multiples from recent Indian startup funding rounds in the same sector. The per-share FMV emerging from this analysis is then the exercise price reference and the Ind AS 102 input.

Ind AS 102 requires the company to recognise the fair value of the option — not the share — as an expense over the vesting period. The option fair value is determined using the Black-Scholes model, which takes the per-share FMV from the IBBI Registered Valuer’s report, the exercise price, the expected volatility estimated from comparable listed peers, the risk-free rate, and the expected option life. This means the IBBI valuer’s equity FMV report is the entry point for the accounting expense calculation, and errors in the valuation flow directly into the P&L impact reported in audited financial statements.

For unlisted companies with non-resident employees receiving ESOPs, FEMA compliance requires an FMV certificate at the time of exercise, when shares are allotted to the non-resident. The FMV at exercise must be determined under a prescribed methodology, and the company must file FC-GPR with the authorised dealer bank. For Mumbai-based financial services companies, tech startups, and NBFCs with multi-jurisdiction employee bases, the ESOP valuation engagement should begin before the scheme is finalised — not after. The grant-date FMV shapes the scheme economics, the accounting expense, and the tax position of every employee who eventually exercises.

The interaction between ESOP schemes and the Income Tax Act at the point of exercise is where most compliance failures accumulate in practice, particularly for pre-IPO companies in Mumbai and high-growth startups that have run multiple ESOP grant tranches at different exercise prices over a multi-year period. At exercise, the perquisite value — the difference between the FMV per share on the exercise date and the exercise price — is taxable in the hands of the employee as salary income, and the employer is obligated to withhold TDS under Section 192 at the marginal tax rate applicable to the employee’s total income including the perquisite. For senior executives exercising large option grants, this perquisite can represent a crore or more of taxable income in a single year, creating a significant TDS obligation that the employer must fund and deposit before it can be recovered from the employee through payroll deduction.

The FMV for this perquisite calculation — as distinct from the Companies Act grant-date FMV calculated by the IBBI Registered Valuer — is prescribed under Rule 3(8) of the Income Tax Rules. For listed shares, the FMV is the average of the opening and closing price on the exercise date on the relevant stock exchange. For unlisted shares, Rule 3(8)(vi) specifies that FMV must be determined as of the exercise date by a Category I Merchant Banker using internationally accepted pricing methodology. This creates a practical challenge for unlisted companies with active ESOP exercise activity — they need a fresh Merchant Banker valuation certificate dated on or close to each exercise event, not a single annual valuation that covers all exercises in the year. Companies that use a year-old valuation report to support multiple exercise events are creating an income tax exposure for both the employer and the employees involved.

The Ind AS 102 accounting for ESOPs in the context of modifications and cancellations is technically complex and frequently mishandled. When an ESOP scheme is modified — for example, when the exercise price is reduced, when additional vesting conditions are added, when the vesting period is extended, or when the performance conditions are changed — Ind AS 102 requires the company to continue recognising the grant-date fair value over the original vesting period, and additionally to recognise any incremental fair value created by the modification from the modification date. The incremental fair value is the difference between the fair value of the modified option and the fair value of the original option, both measured at the modification date. This requires a fresh option pricing calculation as at the modification date, and for companies that have made informal modifications to ESOP terms — as frequently happens when employees negotiate adjusted exercise prices or extended vesting periods in restructuring discussions — the accounting implications may not have been recognised at all, creating an understatement of cumulative compensation expense that auditors increasingly flag.

For Mumbai-based financial services companies, technology businesses, and pre-IPO entities managing multi-tranche ESOP schemes with diverse vesting schedules and performance conditions across a large employee base, the ESOP compliance and accounting exercise is genuinely complex. It requires coordinated professional support across legal, accounting, tax, and valuation disciplines — and the IBBI Registered Valuer’s grant-date equity valuation report is the foundational document on which every other professional input depends.

For further reading on the regulatory framework governing this area, refer to the ICAI guidance on Ind AS 102 — Share-Based Payment, which provides the primary regulatory foundation for the analysis discussed here.

Our Valuation for Regulatory Purposes covers the full range of assignments described in this post. If you need professional valuation assistance, we would be pleased to assist. You can reach out to us here or write to harshulmangal.ca@gmail.com.

ESOP Scheme Design and Valuation Considerations for Pre-IPO Companies

The design of ESOP schemes for companies approaching an IPO creates specific valuation considerations that are absent for perpetual private companies. As a company enters the 12 to 24 month window before its anticipated IPO, the grant-date FMV used for Ind AS 102 expense calculation — and for Section 56(2)(x) protection — begins to converge toward the expected IPO price, because the discount rates applied in the pre-IPO equity valuation decline as the liquidity event horizon approaches. This convergence means that ESOP grants made close to an IPO may carry substantially higher grant-date fair values than grants made two or three years earlier at similar business fundamentals, simply because the DLOM component of the valuation has compressed. Companies that manage their ESOP grant timing — accelerating grants before the pre-IPO FMV re-rating, or structuring grants carefully in the pre-IPO window — can optimise the accounting expense profile while remaining compliant with all regulatory requirements.

The secondary market for pre-IPO ESOP shares has grown significantly in India, driven by employee liquidity programs, secondary transactions facilitated by broking platforms, and direct purchases by pre-IPO funds and family offices. When an employee exercises options and immediately sells shares in a secondary transaction, the income tax perquisite is computed at the FMV on the exercise date — which, for shares transacted in an active secondary market, may now have an observable market price rather than requiring a Merchant Banker certificate. The interaction between Merchant Banker-certified FMV for exercise tax purposes and the observable secondary market price creates a compliance complexity that companies, employees, and their advisors must navigate carefully to avoid under-reporting of perquisite income.